Clinical finding and outcome of total hip replacement in adults with arthritis-100 cases

Background: Total hip replacement (THR) remains the definitive surgical intervention for end-stage hip arthritis. While numerous studies have documented its effectiveness, continuous evaluation of outcomes helps refine surgical techniques and patient selection criteria. This prospective study assessed the clinical outcomes, patient satisfaction, and complications in 100 consecutive cases of primary total hip replacement. Methods: Between January 2022 and December 2023, 100 consecutive patients with hip arthritis underwent primary total hip replacement at our institution. The cohort included both osteoarthritis (85%) and rheumatoid arthritis (15%) cases. All procedures were performed using a standardized posterior approach. Outcomes were evaluated using the Harris Hip Score (HHS), Visual Analog Scale (VAS) for pain, Oxford Hip Score (OHS), and EQ-5D-5L quality of life questionnaire. Radiological assessment and complication rates were documented over a 12-month follow-up period. Results: The mean age of patients was 65.3±8.7 years, with a female predominance (58%). Harris Hip Scores improved significantly from a preoperative mean of 42.5±7.8 to 88.7±6.4 at twelve months (p